Evidence map›Paper›PMID 26577936›Full record

Trial reportJournal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology2016

Effectiveness of intra-articular injections of sodium hyaluronate-chondroitin sulfate in knee osteoarthritis: a multicenter prospective study.

Fabrizio Rivera, Luca Bertignone, Giancarlo Grandi, Roberto Camisassa, Guido Comaschi, Diego Trentini, Marco Zanone, Giuseppe Teppex, Gabriele Vasario, Giorgio Fortina

Erratum issuedOpen access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Osteoarthritis year in review 2017: clinical.Osteoarthritis and cartilage · 2018
    Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Fabrizio RiveraDepartment of Orthopedic Trauma, SS Annunziata Hospital, Savigliano, CN, Italy. rivgio@libero.it.
Luca BertignoneSant'Anna Clinic, Casale Monferrato, AL, Italy.
Giancarlo GrandiLa Vialarda Clinic, Biella, Italy.
Roberto CamisassaLa Vialarda Clinic, Biella, Italy.
Guido ComaschiSestri Ponente Hospital, Genova, Italy.
Diego TrentiniDepartment of Orthopedics and Traumatology, IRCCS A.O.U. San Martino-IST, Genova, Italy.
Marco ZanoneDepartment of Orthopedics and Traumatology, AO CTO Hospital, Turin, Italy.
Giuseppe TeppexDepartment of Orthopedics and Traumatology, AO CTO Hospital, Turin, Italy.
Gabriele VasarioDepartment of Orthopedics and Traumatology, AO CTO Hospital, Turin, Italy.
Giorgio FortinaSanta Rita Clinic, Vercelli, Italy.
CTO Hospital · ITOspedale degli Infermi · ITOspedale Civile Di Ivrea · ITOspedale Policlinico San Martino · ITOspedale SS. Annunziata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntra-articular injection of hyaluronic acid is a well-established therapy for the treatment of knee osteoarthritis. The aim of the study was to assess the effectiveness and safety of the use of Arthrum HCS(®) (40 mg hyaluronic acid and 40 mg chondroitin sulfate in 2 mL). MATERIALS AND

methodsThis was an open, multicenter, prospective study. Men or women over 40 years of age with documented knee osteoarthritis and WOMAC subscore A (severity of pain) ≥25 were enrolled. They received three weekly intra-articular injections of sodium hyaluronate 2 % and chondroitin sulfate 2 % in combination. WOMAC subscore A was assessed at 1, 3 and 6 months after the last injection.

resultsOne hundred and twelve patients were included (women, 66 %). The mean (SD) WOMAC subscore A decreased from 52.1 (15.2) at inclusion to 20.5 (19.7) at month 6 (P < 0.0001). The mean subscore was already significantly decreased 1 month after the last injection at 25.7 (P < 0.0001). Pain relief and consumption of analgesic drugs, both assessed with visual analogic scale (VAS), consistently decreased. The investigators were satisfied/very satisfied as regards the therapeutic effectiveness of sodium hyaluronate-chondroitin sulfate in reducing pain (77 %), improving mobility (78 %) and reducing the consumption of analgesics (74 %). Only one adverse effect was reported by one patient (knee tumefaction).

conclusionThese results suggest that intra-articular injections of Arthrum HCS(®) (sodium hyaluronate plus chondroitin sulfate) in patients with knee osteoarthritis are efficient and safe. These results should be confirmed in a randomized controlled study. LEVEL OF EVIDENCE: IV.

Indexed as

AgedAged, 80 and overArthralgiaChondroitin SulfatesDose-Response Relationship, DrugDrug CombinationsFemaleHumansHyaluronic AcidInjections, Intra-ArticularMaleMiddle AgedOsteoarthritis, KneePain MeasurementProspective StudiesTreatment OutcomeChondroitin Sulfateschondroitin sulfate, sodium hyaluronate drug combinationDrug CombinationsHyaluronic AcidChondroitin sulfateIntra-articular injectionKnee osteoarthritisSodium hyaluronate

Identifiers

PMID26577936
PMCPMC4805636
OpenAlexW2175999474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.